Rigel Pharmaceuticals Inc
General ticker "RIGL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $401.7M
Rigel Pharmaceuticals Inc follows the US Stock Market performance with the rate: 40.7%.
Estimated limits based on current volatility of 3.7%: low 16.36$, high 17.62$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.57$, 17.77$]
- 2024-12-30 to 2025-12-30 estimated range: [8.09$, 18.55$]
Financial Metrics affecting the RIGL estimates:
- Negative: Non-GAAP EPS, $ of -0.15 <= 0.10
- Negative: Operating profit margin, % of -14.92 <= 1.03
- Negative: Operating cash flow per share per price, % of -2.68 <= 2.35
- Negative: negative Net income
- Negative: Inventory ratio change, % of 6.97 > 1.08
- Positive: -0.96 < Investing cash flow per share, $ of -0.25
- Negative: -0.39 < Industry inventory ratio change (median), % of 0
Short-term RIGL quotes
Long-term RIGL plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $149.24MM | $120.24MM | $116.88MM |
Operating Expenses | $161.73MM | $175.79MM | $137.37MM |
Operating Income | $-12.50MM | $-55.55MM | $-20.49MM |
Non-Operating Income | $-4.81MM | $-3.02MM | $-4.60MM |
Interest Expense | $4.86MM | $3.71MM | $6.87MM |
R&D Expense | $65.24MM | $60.27MM | $24.52MM |
Income(Loss) | $-17.31MM | $-58.57MM | $-25.09MM |
Taxes | $0.60MM | $0.00MM | $0.00MM |
Profit(Loss) | $-17.91MM | $-58.57MM | $-25.09MM |
Stockholders Equity | $30.37MM | $-13.62MM | $-28.64MM |
Inventory | $6.62MM | $9.12MM | $5.52MM |
Assets | $167.33MM | $134.28MM | $117.22MM |
Operating Cash Flow | $5.88MM | $-73.76MM | $-5.74MM |
Capital expenditure | $0.63MM | $0.45MM | $15.00MM |
Investing Cash Flow | $-80.04MM | $72.78MM | $-4.30MM |
Financing Cash Flow | $62.67MM | $6.55MM | $18.37MM |
Earnings Per Share* | $-1.05 | $-3.40 | $-1.44 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.